SCHEMBL21484780

SCHEMBL21484780

CC(C)(C)c1cc(/C=C(\C#N)C(=O)Nc2nc(-c3ccc(OC(F)(F)F)cc3)cs2)cc(C(C)(C)C)c1O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRE11 P49959 5/20 0.51
MGAM O43451 1/20 0.45
GAA P10253 1/20 0.45
SI P14410 1/20 0.45
MGAM2 Q2M2H8 1/20 0.45
CSNK2A1 P68400 3/20 0.44
CSNK2A2 P19784 2/20 0.44
CSNK2B P67870 2/20 0.44
CSNK2A3 Q8NEV1 2/20 0.44
EGFR P00533 1/20 0.43
LMNA P02545 2/20 0.42
MPL P40238 1/20 0.41
TRPA1 O75762 1/20 0.41
ALOX5 P09917 1/20 0.41
ROCK1 Q13464 1/20 0.40
SRPK1 Q96SB4 1/20 0.40
MAPT P10636 2/20 0.39
RECQL P46063 2/20 0.39
GSTO1 P78417 1/20 0.39
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21484811 0.90 MRE11 (0.52) MRE11CSNK2A1CSNK2A2CSNK2BCSNK2A3
SCHEMBL21484641 0.88 MRE11 (0.62) MRE11CSNK2A1CSNK2A2CSNK2BCSNK2A3
SCHEMBL21484751 0.88 MRE11 (0.51) MRE11MGAMGAASIMGAM2
SCHEMBL21484735 0.87 LMNA (0.48) MRE11MGAMGAASIMGAM2
SCHEMBL21484750 0.85 MRE11 (0.60) MRE11CSNK2A1CSNK2A2CSNK2BCSNK2A3
SCHEMBL21484858 0.82 MRE11 (0.50) MRE11MGAMGAASIMGAM2
SCHEMBL21484670 0.79 MRE11 (0.61) MRE11GAAEGFRLMNAMAPT
SCHEMBL21484671 0.79 MRE11 (0.60) MRE11CSNK2A1EGFRLMNAMAPT
SCHEMBL21484777 0.78 MRE11 (0.51) MRE11CSNK2A1CSNK2A2CSNK2BCSNK2A3
SCHEMBL21484857 0.78 MRE11 (0.51) MRE11MGAMGAASIMGAM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11584742-B2 Substituted aminothiazoles as inhibitors of nucleases MASARYKOVA UNIVERZITA (CZ) 2023-02-21 US disclosed
US-11584742-B2 Substituted aminothiazoles as inhibitors of nucleases MASARYKOVA UNIVERZITA (CZ) 2023-02-21 US disclosed
US-20220002282-A1 SUBSTITUTED AMINOTHIAZOLES AS INHIBITORS OF NUCLEASES MASARYKOVA UNIVERZITA (CZ) 2022-01-06 US disclosed
US-20220002282-A1 SUBSTITUTED AMINOTHIAZOLES AS INHIBITORS OF NUCLEASES MASARYKOVA UNIVERZITA (CZ) 2022-01-06 US disclosed
EP-3556755-B1 SUBSTITUTED AMINOTHIAZOLES AS INHIBITORS OF NUCLEASES UNIV MASARYKOVA (CZ) 2021-11-17 EP disclosed
EP-3556755-B1 SUBSTITUTED AMINOTHIAZOLES AS INHIBITORS OF NUCLEASES UNIV MASARYKOVA (CZ) 2021-11-17 EP disclosed
WO-2019201865-A1 SUBSTITUTED AMINOTHIAZOLES AS INHIBITORS OF NUCLEASES MASARYKOVA UNIVERZITA (CZ) 2019-10-24 WO disclosed
EP-3556755-A1 SUBSTITUTED AMINOTHIAZOLES AS INHIBITORS OF NUCLEASES Masarykova univerzita (CZ) 2019-10-23 EP disclosed
EP-3556755-A1 SUBSTITUTED AMINOTHIAZOLES AS INHIBITORS OF NUCLEASES Masarykova univerzita (CZ) 2019-10-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11584742-B2 Substituted aminothiazoles as inhibitors of nucleases RNASEH1, DNASE1, FEN1 MRE11 68/4885MGAM 2405/4885GAA 597/4885
US-20220002282-A1 SUBSTITUTED AMINOTHIAZOLES AS INHIBITORS OF NUCLEASES RNASEH1, DNASE1, FEN1 MRE11 68/4885MGAM 2405/4885GAA 597/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.